CSIMarket
 


Organicell Regenerative Medicine Inc   (BPSR)
Other Ticker:  
 
 

BPSR's Revenue Growth by Quarter and Year

Organicell Regenerative Medicine Inc 's Revenue results by quarter and year




BPSR Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter October - 0.98 0.59 0.66
III Quarter July 1.37 0.77 0.58 0.21
II Quarter April 1.20 0.61 0.36 0.09
I Quarter January 1.37 0.70 0.18 0.42
FY   3.94 3.06 1.71 1.38



BPSR Revenue third quarter 2021 Y/Y Growth Comment
Organicell Regenerative Medicine Inc achieved in the third quarter, above Company average Revenue rise of 77.65% year on year, to $ 1.37 millions.

Looking into third quarter results within Biotechnology & Pharmaceuticals industry 43 other companies have achieved higher Revenue growth. While Organicell Regenerative Medicine Inc ' s Revenue jump of 77.65% ranks overall at the positon no. 838 in the third quarter.




BPSR Revenue ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter October - 66.1 % -10.61 % 153.85 %
III Quarter July 77.65 % 32.76 % 176.19 % 23.53 %
II Quarter April 96.72 % 69.44 % 300 % -35.71 %
I Quarter January 95.71 % 288.89 % -57.14 % -
FY   - 78.95 % 23.91 % 142.11 %

Financial Statements
Organicell Regenerative Medicine Inc 's third quarter 2021 Revenue $ 1.37 millions BPSR's Income Statement
Organicell Regenerative Medicine Inc 's third quarter 2020 Revenue $ 0.77 millions Quarterly BPSR's Income Statement
New: More BPSR's historic Revenue Growth >>


BPSR Revenue (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter October - 27.27 % 1.72 % 214.29 %
III Quarter July 13.99 % 26.23 % 61.11 % 133.33 %
II Quarter April -12.41 % -12.86 % 100 % -78.57 %
I Quarter January 39.8 % 18.64 % -72.73 % 61.54 %
FY (Year on Year)   - 78.95 % 23.91 % 142.11 %




Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #44
Healthcare Sector #160
Overall #838

Revenue Y/Y Growth Statistics
High Average Low
116.69 % 31.22 % -48.45 %
(March 31, 2016)   (Jan 31 2017)
Revenue third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #44
Healthcare Sector #160
Overall #838
Revenue Y/Y Growth Statistics
High Average Low
116.69 % 31.22 % -48.45 %
(March 31, 2016)   (Jan 31 2017)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Organicell Regenerative Medicine Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
23832.48 % 984.08 % -77.84 %
(Apr 30 2017)  


BPSR's III. Quarter Q/Q Revenue Comment
Organicell Regenerative Medicine Inc achieved in the III. Quarter 2021 below company average Revenue rise of 13.99% quarter on quarter, to $ 1.37 millions.

Within Biotechnology & Pharmaceuticals industry 55 other companies have achieved higher Revenue quarter on quarter growth. While Organicell Regenerative Medicine Inc 's Revenue growth quarter on quarter, overall rank is 1206.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #56
Healthcare Sector #221
Overall #1206
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #56
Healthcare Sector #221
Overall #1206
Revenue Q/Q Growth Statistics
High Average Low
23832.48 % 984.08 % -77.84 %
(Apr 30 2017)  


BPSR's III. Quarter Q/Q Revenue Comment
Organicell Regenerative Medicine Inc achieved in the III. Quarter 2021 below company average Revenue rise of 13.99% quarter on quarter, to $ 1.37 millions.

Within Biotechnology & Pharmaceuticals industry 55 other companies have achieved higher Revenue quarter on quarter growth. While Organicell Regenerative Medicine Inc 's Revenue growth quarter on quarter, overall rank is 1206.


Organicell Regenerative Medicine Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jul 31 2021)
12 Months Ending
(Apr 30 2021)
12 Months Ending
(Jan 31 2021)
12 Months Ending
(Oct 31 2020)
12 Months Ending
(Jul 31 2020)
Cumulative Revenue 12 Months Ending $ 4.91 $ 4.31 $ 3.73 $ 3.06 $ 2.66
Y / Y Revenue Growth (TTM) 84.89 % 74.69 % 67.65 % 79.51 % 49.85 %
Year on Year Revenue Growth Overall Ranking # 294 # 246 # 129 # 241 # 244
Seqeuential Revenue Change (TTM) 13.92 % 15.74 % 21.97 % 14.96 % 7.64 %
Seq. Revenue Growth (TTM) Overall Ranking # 846 # 394 # 330 # 333 # 335




Cumulative Revenue growth Comment
Although Organicell Regenerative Medicine Inc 's Annual Revenue growth year on year were below company's average 224.77% , Revenue announced in the Jul 31 2021 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 84.89% year on year, from 74.69% in Apr 30 2021.

In the Healthcare sector 94 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 246 to 294.

Revenue TTM Q/Q Growth Statistics
High Average Low
116.69 %
31.22 %
-48.45 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 47
Healthcare Sector # 95
Overall # 294

Revenue TTM Y/Y Growth Statistics
High Average Low
1187.04 %
224.77 %
-44.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 47
Sector # 163
S&P 500 # 846
Cumulative Revenue growth Comment
Although Organicell Regenerative Medicine Inc 's Annual Revenue growth year on year were below company's average 224.77% , Revenue announced in the Jul 31 2021 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 84.89% year on year, from 74.69% in Apr 30 2021.

In the Healthcare sector 94 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 246 to 294.

Revenue TTM Q/Q Growth Statistics
High Average Low
116.69 %
31.22 %
-48.45 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 47
Healthcare Sector # 95
Overall # 294

Revenue TTM Y/Y Growth Statistics
High Average Low
1187.04 %
224.77 %
-44.44 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 47
Sector # 163
S&P 500 # 846




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BPSR's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for BPSR's Competitors
Revenue Growth for Organicell Regenerative Medicine Inc 's Suppliers
Revenue Growth for BPSR's Customers

You may also want to know
BPSR's Annual Growth Rates BPSR's Profitability Ratios BPSR's Asset Turnover Ratio BPSR's Dividend Growth
BPSR's Roe BPSR's Valuation Ratios BPSR's Financial Strength Ratios BPSR's Dividend Payout Ratio
BPSR's Roa BPSR's Inventory Turnover Ratio BPSR's Growth Rates BPSR's Dividend Comparisons



Companies with similar Revenue rise for the quarter ending Jul 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jul 31 2021
Envista Holdings Corporation104.45%$ 104.448 millions
Organicell Regenerative Medicine Inc 78.27%$ 78.266 millions
Staar Surgical Co77.21%$ 77.209 millions
Exelixis Inc 48.44%$ 48.442 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MCAE's Profile

Stock Price

MCAE's Financials

Business Description

Fundamentals

Charts & Quotes

MCAE's News

Suppliers

MCAE's Competitors

Customers & Markets

Economic Indicators

MCAE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071